{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T07:52:13Z","timestamp":1685692333070},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s10620-023-07866-9","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T03:02:48Z","timestamp":1679022168000},"page":"1709-1713","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Excipient Exception: A Complication of Infliximab and Vedolizumab Infusions for Ulcerative Colitis"],"prefix":"10.1007","volume":"68","author":[{"given":"Rahul S.","family":"Dalal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behiye","family":"Goksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"7866_CR1","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.cgh.2017.05.050","volume":"15","author":"E Mansoor","year":"2017","unstructured":"Mansoor E, Saleh MA, Cooper GS. Prevalence of eosinophilic gastroenteritis and colitis in a population-based study, from 2012 to 2017. Clin Gastroenterol Hepatol. 2017;15:1733\u20131741. https:\/\/doi.org\/10.1016\/j.cgh.2017.05.050.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7866_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jgh.13463","volume":"32","author":"M Zhang","year":"2017","unstructured":"Zhang M, Li Y. Eosinophilic gastroenteritis: A state-of-the-art review. J Gastroenterol Hepatol. 2017;32:64\u201372. https:\/\/doi.org\/10.1111\/jgh.13463.","journal-title":"J Gastroenterol Hepatol."},{"key":"7866_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.gtc.2014.02.007","volume":"43","author":"MH Collins","year":"2014","unstructured":"Collins MH. Histopathologic features of eosinophilic esophagitis and eosinophilic gastrointestinal diseases. Gastroenterol Clin North Am. 2014;43:257\u2013268. https:\/\/doi.org\/10.1016\/j.gtc.2014.02.007.","journal-title":"Gastroenterol Clin North Am."},{"key":"7866_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S2468-1253(18)30005-0","volume":"3","author":"MM Walker","year":"2018","unstructured":"Walker MM, Potter M, Talley NJ. Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus. Lancet Gastroenterol Hepatol. 2018;3:271\u2013280. https:\/\/doi.org\/10.1016\/S2468-1253(18)30005-0.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"7866_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4292\/wjgpt.v7.i4.513","volume":"7","author":"A Abou Rached","year":"2016","unstructured":"Abou Rached A, El Hajj W. Eosinophilic gastroenteritis: Approach to diagnosis and management. World J Gastrointest Pharmacol Ther. 2016;7:513\u2013523. https:\/\/doi.org\/10.4292\/wjgpt.v7.i4.513.","journal-title":"World J Gastrointest Pharmacol Ther."},{"key":"7866_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/MPG.0000000000003512","volume":"75","author":"N Patel","year":"2022","unstructured":"Patel N, Goyal A, Thaker A, Troendle D, Parrish C. A case series on the use of dupilumab for treatment of refractory eosinophilic gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2022;75:192\u2013195. https:\/\/doi.org\/10.1097\/MPG.0000000000003512.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"7866_CR7","first-page":"405","volume":"96","author":"D Bacha","year":"2018","unstructured":"Bacha D, Walha M, Ben Slama S et al. Chronic gastritis classifications. Tunis Med. 2018;96:405\u2013410.","journal-title":"Tunis Med."},{"key":"7866_CR8","unstructured":"eHealthMe. https:\/\/www.ehealthme.com\/"},{"key":"7866_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000334805","volume":"223","author":"B Malisiewicz","year":"2011","unstructured":"Malisiewicz B, Murer C, Pachlopnik Schmid J, French LE, Schmid-Grendelmeier P, Navarini AA. Eosinophilia during psoriasis treatment with TNF antagonists. Dermatology. 2011;223:311\u2013315. https:\/\/doi.org\/10.1159\/000334805.","journal-title":"Dermatology."},{"key":"7866_CR10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1136\/ard.2005.044685","volume":"65","author":"P Boura","year":"2006","unstructured":"Boura P, Sarantopoulos A, Lefaki I, Skendros P, Papadopoulos P. Eosinophilic cellulitis (Wells\u2019 syndrome) as a cutaneous reaction to the administration of adalimumab. Ann Rheum Dis. 2006;65:839\u2013840. https:\/\/doi.org\/10.1136\/ard.2005.044685.","journal-title":"Ann Rheum Dis."},{"key":"7866_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/j.1468-3083.2011.04169.x","volume":"26","author":"K Vester","year":"2012","unstructured":"Vester K, R\u00fcger RD, Harth W, Simon JC. Transient blood eosinophilia during treatment with Adalimumab. J Eur Acad Dermatol Venereol. 2012;26:924\u2013925. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04169.x.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"7866_CR12","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.2169\/internalmedicine.4554-20","volume":"59","author":"S Hayashida","year":"2020","unstructured":"Hayashida S, Sato S, Shimada Y et al. Eosinophilic gastroenteritis in an ulcerative colitis patient during treatment with tumor necrosis factor-alpha antagonist. Intern Med. 2020;59:1977\u20131981. https:\/\/doi.org\/10.2169\/internalmedicine.4554-20.","journal-title":"Intern Med."},{"key":"7866_CR13","doi-asserted-by":"publisher","first-page":"e00905","DOI":"10.14309\/crj.0000000000000905","volume":"9","author":"D De Marco","year":"2022","unstructured":"De Marco D, Bessissow T, Marcus V, Benmassaoud A. Vedolizumab-associated hypereosinophilia and hepatoxicity. ACG Case Rep J. 2022;9:e00905. https:\/\/doi.org\/10.14309\/crj.0000000000000905.","journal-title":"ACG Case Rep J."},{"key":"7866_CR14","doi-asserted-by":"publisher","first-page":"942237","DOI":"10.3389\/fmed.2022.942237","volume":"9","author":"W Zhu","year":"2022","unstructured":"Zhu W, Zhao T, Wei J et al. Case report: Eosinophilic pneumonia associated with vedolizumab therapy in a patient with ulcerative colitis. Front Med (Lausanne). 2022;9:942237. https:\/\/doi.org\/10.3389\/fmed.2022.942237.","journal-title":"Front Med (Lausanne)."},{"key":"7866_CR15","unstructured":"Medication Guide, Remicade. Accessed 12\/18\/2022, https:\/\/www.janssenlabels.com\/package-insert\/product-patient-information\/REMICADE-medication-guide.pdf"},{"key":"7866_CR16","unstructured":"Medication Guide, Entyvio. Accessed 12\/18\/2022, https:\/\/www.general.takedapharm.com\/ENTYVIOMG"},{"key":"7866_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/s0140-6736(95)90963-x","volume":"345","author":"WB Shelley","year":"1995","unstructured":"Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensitivity. Lancet. 1995;345:1312\u20131313. https:\/\/doi.org\/10.1016\/s0140-6736(95)90963-x.","journal-title":"Lancet."},{"key":"7866_CR18","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.2169\/internalmedicine.56.8168","volume":"56","author":"N Azuma","year":"2017","unstructured":"Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H. Successful switch to golimumab for eosinophilia and skin symptoms related to multiple biologics in a patient with rheumatoid arthritis. Intern Med. 2017;56:1585\u20131590. https:\/\/doi.org\/10.2169\/internalmedicine.56.8168.","journal-title":"Intern Med."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-07866-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07866-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T04:22:23Z","timestamp":1682482943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-07866-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["7866"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-07866-9","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"28 January 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Matthew Hamilton: Educational grants from Takeda, Abbvie, Pfizer; Rahul Dalal: Research grants from Janssen and Pfizer, consultant for Janssen and Centaur labs; Behiye Goksel: None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}